Theradaptive Inc.

Frederick, MD

UEI
DN45N68LM8M6
CAGE
7AQS5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Veteran Owned Business
  • Hispanic American Owned
  • Service Disabled Veteran Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Founded
2017
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
59 Miscellaneous Retail
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Grant awards

Similar vendors

About the company

Theradaptive Inc. is an innovative company developing a therapeutic delivery platform for multiple clinical indications including orthopedic repair. Through federal contract and grant awards, Theradaptive provides research, development, and clinical services related to conformable scaffolds, sustained-release implants, and other regenerative medicine technologies.

Theradaptive has been awarded a $549,031 firm fixed price definitive contract by the Defense Health Agency to support Phase II Enhancement of an SBIR project titled "Conformable Osteochondral Repair Platforms for Prevention of Post Traumatic Osteoarthritis." This contract, set aside for total small businesses, funds continued R&D over 15 months on conformable scaffolds to repair cartilage and bone damage from trauma. As a subcontractor, Theradaptive is also evaluating technologies to render orthopedic implants biologically active through a contract between the Geneva Foundation and prime contractor.

Through the Military Medical Research and Development program, Theradaptive has received Project Grant awards from both the Defense Health Agency and Department of the Army Medical Command supporting clinical research and development of sustained-release therapeutics for trauma repair. A $619,439 award is funding a clinical study investigating an implant to facilitate tissue regeneration in trauma patients. Another $3,979,465 award over two years is enabling preclinical and clinical validation of a therapeutic for extremity trauma repair to advance battlefield medicine. Theradaptive previously partnered as a subgrantee on an award focused on engineered tissue storage and transport.

Quick answers

Is Theradaptive Inc. registered in SAM.gov?

Yes. Theradaptive Inc.'s SAM.gov registration is active through March 30, 2027.

What is Theradaptive Inc.'s CAGE code?

Theradaptive Inc.'s CAGE code is 7AQS5, and its Unique Entity ID (UEI) is DN45N68LM8M6.

What is Theradaptive Inc.'s most recent federal award?

Theradaptive Inc.'s most recent federal grant award is Clinical study of sustained-release implant for trauma repair (HT94252310693), from Defense Health Agency, on July 24, 2023.

On GovTribe

See Theradaptive Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe